Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2008
Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III studyLeonard B Saltz, Stephen Clarke, Eduardo Díaz-Rubio, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2023
Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III StudyLeonard B Saltz, Stephen Clarke, Eduardo Díaz-Rubio, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2009
Health-related quality of life in patients with advanced colorectal cancer treated with cetuximab: overall and KRAS-specific results of the NCIC CTG and AGITG CO.17 TrialHeather-Jane Au, Christos S Karapetis, Chris J O'Callaghan, et al.JAMA Oncology|October 14, 2016
Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer: Secondary Analysis of the TRIO-013/LOGiC Randomized Clinical TrialMichael P Chu, J Randolph Hecht, Dennis Slamon, et al.Journal for Immunotherapy of Cancer|December 4, 2024
Plasma arginine as a predictive biomarker for outcomes with immune checkpoint inhibition in metastatic colorectal cancer: a correlative analysis of the CCTG CO.26 trialLucy X Ma, Emma Titmuss, Jonathan M Loree, et al.Clinical Breast Cancer|October 11, 2015
A Uridine Glucuronosyltransferase 2B7 Polymorphism Predicts Epirubicin Clearance and Outcomes in Early-Stage Breast CancerMichael B Sawyer, Edith Pituskin, Sambasivarao Damaraju, et al.JAMA Network Open|December 5, 2023
Liver Metastases and Immune Checkpoint Inhibitor Efficacy in Patients With Refractory Metastatic Colorectal Cancer: A Secondary Analysis of a Randomized Clinical TrialEric X Chen, Jonathan M Loree, Emma Titmuss, et al.The Lancet. Gastroenterology & Hepatology|February 5, 2018
Napabucasin versus placebo in refractory advanced colorectal cancer: a randomised phase 3 trialDerek J Jonker, Louise Nott, Takayuki Yoshino, et al.Pageof 2